Lynn Stockwell
CEO and Exe. Chair of Board at Drugs Made In America Acquisition Corp.
Sits on 2 boards. Last updated September 28, 2026
Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 3 years
- Director since
- 2025
3 years of board service in total across 2 boards, counting each seat separately. Longest: Drugs Made In America Acquisition Corp., 1 year.
Drugs Made In America Acquisition Corp.
Director · CEO and Exe. Chair of Board
Drugs Made In America Acquisition II Corp.
Director · CEO and Exe. Chair of Board
Chief executive roles
Drugs Made In America Acquisition Corp.
· CEO and Exe. Chair of Board
Since January 2025
Drugs Made In America Acquisition II Corp.
· CEO & Exe. Chair of the Board
Since September 2025
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 26, 2025 | Drugs Made In America Acquisition II Corp. | Open-market purchase | +700,000 | — | — |
| Sep 26, 2025 | Drugs Made In America Acquisition II Corp. | Other | −400,000 | — | — |
| Sep 26, 2025 | Drugs Made In America Acquisition II Corp. | Open-market sale | −7,966,667 | — | — |
| Feb 18, 2025 | Drugs Made In America Acquisition Corp. | Open-market purchase | +30,000 | — | — |
| Jan 29, 2025 | Drugs Made In America Acquisition Corp. | Open-market purchase | +400,000 | — | — |
| Jan 29, 2025 | Drugs Made In America Acquisition Corp. | Other | −400,000 | — | — |
| Jan 29, 2025 | Drugs Made In America Acquisition Corp. | Open-market sale | −5,698,363 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.